Cart
sales@molnova.com
Zandelisib
CAS No. 1401436-95-0
Zandelisib ( ME-401; PWT-143 )
Catalog No. M26519 CAS No. 1401436-95-0
Zandelisib is an inhibitor of phosphatidylinositol 3-kinase (PI3K)(p110δ, IC50 of 3.5 nM), and with antineoplastic activity.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 285 | Get Quote |
|
| 10MG | 475 | Get Quote |
|
| 25MG | 770 | Get Quote |
|
| 50MG | 1062 | Get Quote |
|
| 100MG | 1431 | Get Quote |
|
| 500MG | 2862 | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameZandelisib
-
NoteResearch use only, not for human use.
-
Brief DescriptionZandelisib is an inhibitor of phosphatidylinositol 3-kinase (PI3K)(p110δ, IC50 of 3.5 nM), and with antineoplastic activity.
-
DescriptionZandelisib is an inhibitor of phosphatidylinositol 3-kinase (PI3K)(p110δ, IC50 of 3.5 nM), and with antineoplastic activity.(In Vitro):Zandelisib inhibits PI3Ks(p110α, p110β, p110γ and p110δ with IC50s of 4, 976 nM, 605 nM, 817 nM and 3.5 nM, respectivey).
-
SynonymsME-401; PWT-143
-
PathwayPI3K/Akt/mTOR signaling
-
TargetPI3K
-
RecptorApoptosis
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1401436-95-0
-
Formula Weight576.7
-
Molecular FormulaC31H38F2N8O
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESCN1CCC(CC1)c1ccccc1CC(C)(C)Nc1nc(nc(n1)-n1c(nc2ccccc12)C(F)F)N1CCOCC1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Llado V, et al. Minerval induces apoptosis in Jurkat and other cancer cells. J Cell Mol Med. 2010 Mar;14(3):659-70.
molnova catalog
related products
-
SAR405
SAR405 is a highly potent and selective PI3K class III isoform Vps34 inhibitor with IC50 of 1.2 nM.
-
PI-103 hydrochloride
A potent, dual class I PI3K/mTOR inhibitor with IC50 of 2/3/3/15/ for p110α/β/δ/γ, respectively.
-
CYH33
CYH33 (CYH-33) is a novel potent, PI3Kα-selective inhibitor with IC50 of 5.9 nM/598 nM/ 78.7 nM/225 nM aginst class I PI3K isoform α/β/δ/γ, respectively.
